Skip to main content
Fig. 3 | Molecular Medicine

Fig. 3

From: Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome

Fig. 3

Serum analyses in patient #2 before and after treatment with etoposide. Two blood samples taken before and after etoposide therapy were analyzed when normalized levels of HMGB1 (a), ferritin (b) and IFN-γ (c) where documented after intervention with etoposide and subsequent clinical improvement. IL-18 declined but was still elevated (d) while MCP-1 increased (e). CsA cyclosporine A

Back to article page

Molecular Medicine

ISSN: 1528-3658